Monday, October 16, 2017

News on Biosimilars

There has been quite a bit of interesting pharmaceutical policy news and I hope to post more soon.  In the meantime, here is a news item related to my recent posts on biosimilars.  From this story it appears that even the pegylated biologic pegfilgrastim did not present insurmountable difficulties in developing an equally effective, non-immunogenic biosimilar, although the manufacturing issues are still to be resolved.

No comments:

Post a Comment